Matyas Hamar
Overview
Explore the profile of Matyas Hamar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Palla S, Toke J, Bozsik A, Butz H, Papp J, Liko I, et al.
Sci Rep
. 2023 Sep;
13(1):16339.
PMID: 37770543
No abstract available.
2.
Palla S, Toke J, Bozsik A, Butz H, Papp J, Liko I, et al.
Sci Rep
. 2023 Sep;
13(1):14658.
PMID: 37670105
Carney complex (CNC) is an ultrarare disorder causing cutaneous and cardiac myxomas, primary pigmented nodular adrenocortical disease, hypophyseal adenoma, and gonadal tumours. Genetic alterations are often missed under routine genetic...
3.
Stryjak I, Warmuzinska N, Luczykowski K, Hamar M, Urbanellis P, Wojtal E, et al.
J Vis Exp
. 2020 Jul;
(160).
PMID: 32628165
Kidney transplantation is a life-saving treatment for a large number of people with end-stage renal dysfunction worldwide. The procedure is associated with an increased survival rate and greater quality of...
4.
Kollmann D, Linares-Cervantes I, Ganesh S, Rosales R, Hamar M, Goto T, et al.
Transplantation
. 2020 Feb;
104(6):1177-1186.
PMID: 32091485
Background: The detrimental role of platelets in sinusoidal endothelial cell (SEC) injury during liver transplantation (LT) has been previously addressed after static cold storage (SCS), however, it is currently unknown...
5.
Urbanellis P, Hamar M, Kaths J, Kollmann D, Linares I, Mazilescu L, et al.
Transplantation
. 2019 Dec;
104(5):947-955.
PMID: 31815900
Background: Better preservation strategies for the storage of donation after circulatory death grafts are essential to improve graft function and to increase the kidney donor pool. We compared continuous normothermic...
6.
Linares-Cervantes I, Echeverri J, Cleland S, Kaths J, Rosales R, Goto T, et al.
Am J Transplant
. 2019 Apr;
19(11):2991-3005.
PMID: 31012532
Normothermic ex situ liver perfusion (NEsLP) offers the opportunity to assess biomarkers of graft function and injury. We investigated NEsLP parameters (biomarkers and markers) for the assessment of liver viability...
7.
Linares-Cervantes I, Kollmann D, Goto T, Echeverri J, Kaths J, Hamar M, et al.
Transplant Direct
. 2019 Apr;
5(4):e437.
PMID: 30993191
Background: Human albumin/dextran (HA-D), bovine-gelatin (BG), and packed red blood cells plus plasma have been used in European and North-American clinical trials of normothermic ex situ liver perfusion (NEsLP). We...
8.
Wettstein D, Hamar M, Cseprekal O, Toth S, Rozsa B, Remport A, et al.
Orv Hetil
. 2018 Nov;
159(46):1882-1890.
PMID: 30450928
Machine perfusion of marginal grafts might be a possible solution to organ shortage and a promising tool for reducing waiting list morbidity and mortality. In recent years, optimizing the circumstances...
9.
Linares I, Hamar M, Selzner N, Selzner M
Transplantation
. 2018 Nov;
103(1):78-90.
PMID: 30418431
In parallel with the pandemic of obesity and diabetes, the prevalence of nonalcoholic fatty liver disease has progressively increased. Nonalcoholic steatohepatitis (NASH), a subtype of nonalcoholic fatty liver disease has...
10.
Hamar M, Selzner M
Curr Opin Organ Transplant
. 2018 Apr;
23(3):369-374.
PMID: 29697462
Purpose Of Review: Machine perfusion is a novel strategy to decrease preservation injury, improve graft assessment, and increase organ acceptance for transplantation. This review summarizes the current advances in ex-vivo...